| Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704) |
|---|
| 11/18/2004 | WO2004099206A1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof |
| 11/18/2004 | WO2004099202A1 Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases |
| 11/18/2004 | WO2004098590A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 11/18/2004 | WO2004098589A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 11/18/2004 | WO2004087700A8 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain |
| 11/18/2004 | WO2004074246A3 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 11/18/2004 | US20040229955 Antibacterial agents |
| 11/18/2004 | US20040229907 2-Aminoquinolinecarboxamides: neurokinin receptor ligands |
| 11/18/2004 | US20040229893 Substituted benzothiazole amide derivatives |
| 11/18/2004 | CA2524625A1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof |
| 11/18/2004 | CA2524274A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 11/18/2004 | CA2524269A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 11/17/2004 | EP1477488A1 Novel optically active compounds, method for kinetic optical resolution of carboxylic acid derivatives and catalysts therefor |
| 11/17/2004 | EP1476448A2 Azabicyclic compounds for the treatment of disease |
| 11/11/2004 | WO2004096800A2 Quinuclidine derivatives binding to mucarinic m3 receptors |
| 11/11/2004 | WO2004026844A9 Methods and compositions of novel triazine compounds |
| 11/11/2004 | US20040224977 Racemic mixtures for treatment of diseases with alpha 7nicotinic acetyl chloline administering |
| 11/11/2004 | US20040224976 Azabicyclic compounds for the treatment of disease |
| 11/11/2004 | US20040224950 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 11/04/2004 | WO2004074812A3 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 11/04/2004 | WO2003078431A8 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor |
| 11/04/2004 | US20040220214 Pharmaceutical compositions and methods for effecting dopamine release |
| 11/04/2004 | US20040220196 antitumor agents; 4-amino-5-fluoro-3-(6-( 4-methylpiperazin-1-yl)1H-benzimidazol-2-yl)-quinolin-2-one |
| 11/02/2004 | US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression |
| 11/02/2004 | CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | CN1539838A Recoverable repeatable use chirality cinchona alkaloid ligand and application |
| 10/26/2004 | US6809214 Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 10/21/2004 | WO2004089931A1 Substituted pyrazoles |
| 10/21/2004 | US20040209915 substituted with an N- (p-hydroxy-alpha-hydroxybenzylaminoalkylpiperidinyloxy- (or -amino-)carbonylamino group; useful for identifying compounds having both beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 10/21/2004 | US20040209882 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 10/21/2004 | US20040209881 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 10/21/2004 | US20040209880 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |
| 10/21/2004 | US20040209876 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 10/21/2004 | US20040209865 use for reducing body weight and treating urinary incontinence; Melanin-concentrating hormone (MCH); 5-(4-chloro-phenyl)-2-[5-(2-pyrrolidin-1-yl-ethoxy)-pyridin-2-yl-ethynyl]-pyridine for example |
| 10/21/2004 | US20040209860 compounds having a (biphenyl-2-yl)oxycarbonylamino- or (biphenyl-2-yl)aminocarbonylamino-substituted (2-7C)azacycloalkyl or (5-10C)azabicycloalkyl group; and a 2-(4-hydroxyphenyl)-2-hydroxyethylamino group; treating asthma or chronic obstructive pulmonary disease; providing bronchodilation |
| 10/21/2004 | US20040209826 Diphosphate salt of a "4" - substituted-9-deoxo-9 A - AZA - homoerythromycin derivatives and its pharmaceutical composition |
| 10/21/2004 | CA2521201A1 Substituted pyrazoles for use in the prophylaxis or treatment of a disease which can be influenced by the binding of the substitued pyrazoles to 5ht receptors |
| 10/20/2004 | CN1538845A Phenyl derivatives as factor Xa inhibitors |
| 10/19/2004 | CA2081315C Heterocyclic chiral ligands and method for catalytic asymmetric dihydroxylation of olefins |
| 10/14/2004 | WO2004087700A1 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain |
| 10/14/2004 | WO2004087696A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 10/14/2004 | US20040204460 Sodium channel modulators |
| 10/14/2004 | DE10315572A1 Substituierte Pyrazole Substituted pyrazoles |
| 10/14/2004 | CA2520894A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 10/13/2004 | EP1466912A1 2-acylaminothiazole derivative or salt thereof |
| 10/13/2004 | EP1465488A1 Arylamines as inhibitors of chemokine binding to us28 |
| 10/07/2004 | WO2004084898A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 10/07/2004 | WO2004074276B1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 10/07/2004 | WO2003078430A8 Amides of acetic and propionic acids |
| 10/06/2004 | EP1144403B1 Substituted pyrazoles as p38 kinase inhibitors |
| 10/06/2004 | EP1085000B1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 10/05/2004 | US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase |
| 10/05/2004 | CA2087035C Heterocyclic chiral ligands and method for catalytic asymmetric dihydroxylation of olefins |
| 09/30/2004 | WO2004043349A3 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 09/30/2004 | US20040192687 Dna-pk inhibitors |
| 09/29/2004 | EP1461336A2 1-alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 09/29/2004 | EP1461335A1 2-heteroarylcarboxylic acid amides |
| 09/29/2004 | EP1028961B1 Pleuromutilin derivatives as antimicrobials |
| 09/29/2004 | CN1532196A Quinic compound containing quaternary ammonium group and its preparation and medicina use |
| 09/28/2004 | US6797730 Peptide deformylase inhibitors |
| 09/23/2004 | WO2004039815A8 Compounds having both alpha7 nachr agonist and 5ht antagonist activity for treatment of cns diseases |
| 09/22/2004 | EP1458716A1 Bicyclic n-arylamides |
| 09/22/2004 | CN1167703C Azabicyclic carbamates and their use as alpha-7 nicotinic acetyl choline receptor agonists |
| 09/21/2004 | US6794532 Hydrogenation of prochiral ketones |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/21/2004 | CA2155843C Novel urea derivatives, their preparation and use |
| 09/16/2004 | WO2004078686A1 Process for producing optically active alcohol in the presence of rhodium, a chiral ferrocenyldiphosphine and an optically active diamine |
| 09/16/2004 | WO2004043389B1 Methods of treating cancer and related methods |
| 09/16/2004 | WO2003091207A3 Method of preparing amine stereoisomers |
| 09/16/2004 | US20040180923 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction |
| 09/16/2004 | US20040180877 Nicotinic acetylcholine receptor cholinergic ligands, monoamine receptor and transporter modulators; such as 1-(2-Benzo[b]thiophenyl-1,1-dioxide)-imidazolidine |
| 09/15/2004 | EP1457488A1 Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity |
| 09/15/2004 | EP1456175A1 Substituted heterocyclic carboxamides with antithrombotic activity |
| 09/15/2004 | EP1455792A1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 09/15/2004 | EP1077925B1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 09/15/2004 | CN1529600A Use of NK-1-receptor antagonists tomodify unwanted behavior indogs, casts and horses |
| 09/10/2004 | WO2004076449A2 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 09/10/2004 | WO2004076448A1 Ccr-3 receptor antagonists |
| 09/10/2004 | WO2004034985A3 Chemical compounds |
| 09/10/2004 | CA2516634A1 Ccr-3 receptor antagonists |
| 09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 09/09/2004 | US20040176416 Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists |
| 09/09/2004 | US20040176396 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 09/09/2004 | US20040176361 2H-Isoquinolin-1-one derivatives as poly/ADP-ribose/ polymerase inhibitors |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP0994876B1 Quaternary ammonium compounds as tachykinin antagonists |
| 09/08/2004 | CN1527708A Medicinal composition for treating interstitial cystitis |
| 09/07/2004 | US6787652 Lowering lipids and serum cholesterol without generating adverse cardiac effects; 4,5-dihydro-3,5-dioxo-1,2,4-triazine derivatives |
| 09/02/2004 | WO2004074812A2 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/02/2004 | WO2004074276A1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY |
| 09/02/2004 | WO2004074246A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/02/2004 | CA2515777A1 Biphenyl derivatives |
| 09/01/2004 | EP1452534A1 Pleuromutlin derivatives as antimicrobials |
| 09/01/2004 | EP1452527A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
| 09/01/2004 | EP1451176A2 Benzazepine derivatives and their use as 5-ht ligands |
| 09/01/2004 | EP1450801A2 2-aminoquinoline compounds |
| 09/01/2004 | CN1525968A Compositions for prevention or treatment of hepatopathy |
| 08/31/2004 | US6784200 Such as n-3-(cis-2,3,3a,4,9,9a-hexahydro-1h-benz(f)isoindol-2-yl)-n-prop-1-yl-n'-3 -acetylphenylurea for prevention of inflammatory diseases (asthma and allergies) |